PMID- 30189266 OWN - NLM STAT- MEDLINE DCOM- 20200214 LR - 20210109 IS - 1873-4596 (Electronic) IS - 0891-5849 (Linking) VI - 133 DP - 2019 Mar TI - Circadian control of BDNF-mediated Nrf2 activation in astrocytes protects dopaminergic neurons from ferroptosis. PG - 169-178 LID - S0891-5849(18)31523-5 [pii] LID - 10.1016/j.freeradbiomed.2018.09.002 [doi] AB - Astrocyte-neuron interactions protect neurons from iron-mediated toxicity. As dopamine can be metabolized to reactive quinones, dopaminergic neurons are susceptible to oxidative damage and ferroptosis-like induced cell death. Detoxification enzymes are required to protect neurons. Brain-derived neurotrophic factor (BDNF) plays a key role in the regulation of redox sensitive transcription factor Nrf2 in astrocytes and metabolic cooperation between astrocytes and neurons. This article reviews the importance of BDNF and astrocyte-neuron interactions in the protection of neurons against oxidative damages in rodent brains. We previously proposed that BDNF activates Nrf2 via the truncated TrkB.T1 and p75(NTR) receptor complex in astrocytes. Stimulation by BDNF generates the signaling molecule ceramide, which activates PKCzeta leading to induction of the CK2-Nrf2 signaling axis. As a cell clock regulates p75(NTR) expression, we suggested that BDNF effectively activates Nrf2 in astrocytes during the rest phase. In contrast, neurons express both TrkB.FL and TrkB.T1, and TrkB.FL tyrosine kinase activity inhibits p75(NTR)-dependent ceramide generation and internalizes p75(NTR). Therefore, BDNF may not effectively activate Nrf2 in neurons. Notably, neurons only weakly activate detoxification and antioxidant enzymes/proteins via the Nrf2-ARE signaling axis. Thus, astrocytes may provide relevant transcripts and/or proteins to neurons via microparticles/exosomes increasing neuronal resistance to oxidative stress. Circadian increases in the levels of circulating glucocorticoids may further facilitate material transfer from astrocytes to neurons via the stimulation of pannexin 1 channels-P2X7R signaling pathway in astrocytes at the beginning of the active phase. Dysregulation of astrocyte-neuron interactions could therefore contribute to the pathogenesis of neurodegenerative diseases including Parkinson's disease. CI - Copyright (c) 2018 Elsevier Inc. All rights reserved. FAU - Ishii, Tetsuro AU - Ishii T AD - School of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8577, Japan. Electronic address: ishiitetsuro305@gmail.com. FAU - Warabi, Eiji AU - Warabi E AD - School of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8577, Japan. FAU - Mann, Giovanni E AU - Mann GE AD - School of Cardiovascular Medicine and Sciences, King's British Heart Foundation Centre of Research Excellence, Faculty of Life Sciences and Medicine, King's College London, London SE1 9NH, UK. LA - eng GR - FS/15/6/31298/BHF_/British Heart Foundation/United Kingdom GR - FS/16/67/32548/BHF_/British Heart Foundation/United Kingdom GR - MRC_/Medical Research Council/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20180904 PL - United States TA - Free Radic Biol Med JT - Free radical biology & medicine JID - 8709159 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Membrane Glycoproteins) RN - 0 (NF-E2-Related Factor 2) RN - 0 (Nfe2l2 protein, mouse) RN - E1UOL152H7 (Iron) RN - EC 2.7.10.1 (Ntrk2 protein, mouse) RN - EC 2.7.10.1 (Protein-Tyrosine Kinases) SB - IM MH - Animals MH - Astrocytes/metabolism MH - Brain-Derived Neurotrophic Factor/*genetics/metabolism MH - Circadian Clocks/genetics MH - Dopaminergic Neurons/*metabolism MH - Ferroptosis/genetics MH - Iron/*metabolism MH - Membrane Glycoproteins/genetics/metabolism MH - Mice MH - NF-E2-Related Factor 2/*genetics/metabolism MH - Oxidative Stress/genetics MH - Parkinson Disease/genetics/metabolism/pathology MH - Protein-Tyrosine Kinases/genetics/metabolism MH - Rats MH - Rodentia OTO - NOTNLM OT - BDNF OT - CK2 OT - Circadian rhythm OT - Cystine transport OT - Dopamine OT - Ferroptosis OT - GSH OT - Mitochondria OT - Nrf2 OT - PKA OT - Parkinson's disease OT - TrkB OT - p75(NTR) EDAT- 2018/09/07 06:00 MHDA- 2020/02/15 06:00 CRDT- 2018/09/07 06:00 PHST- 2018/07/09 00:00 [received] PHST- 2018/08/20 00:00 [revised] PHST- 2018/09/01 00:00 [accepted] PHST- 2018/09/07 06:00 [pubmed] PHST- 2020/02/15 06:00 [medline] PHST- 2018/09/07 06:00 [entrez] AID - S0891-5849(18)31523-5 [pii] AID - 10.1016/j.freeradbiomed.2018.09.002 [doi] PST - ppublish SO - Free Radic Biol Med. 2019 Mar;133:169-178. doi: 10.1016/j.freeradbiomed.2018.09.002. Epub 2018 Sep 4.